We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$268B
AUM Growth
+$45.9B
Cap. Flow
+$30.5B
Cap. Flow %
11.36%
Top 10 Hldgs %
29.82%
Holding
5,008
New
209
Increased
2,223
Reduced
1,248
Closed
867

Sector Composition

Rank Sector Weight
1 Technology 14.97%
2 Financials 8.75%
3 Healthcare 7.15%
4 Consumer Discretionary 6.46%
5 Communication Services 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIGR
3526
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$202K ﹤0.01%
1,295
+859
+197% +$166K
IEP icon
3527
Icahn Enterprises
IEP
$5.22B
$200K ﹤0.01%
4,038
-9,043
-69% -$481K
CARM
3528
DELISTED
Carisma Therapeutics
CARM
$199K ﹤0.01%
12,217
+8,055
+194% +$162K
CMCL icon
3529
Caledonia Mining Corp
CMCL
$352M
$199K ﹤0.01%
17,076
+10,551
+162% +$131K
BCEL
3530
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$199K ﹤0.01%
65,735
+33,480
+104% +$156K
DNTH icon
3531
Dianthus Therapeutics
DNTH
$5.88B
$198K ﹤0.01%
2,793
+1,505
+117% +$151K
CBFV icon
3532
CB Financial Services
CBFV
$191M
$197K ﹤0.01%
8,198
-477
-5% -$11.4K
ISTR icon
3533
Investar Holding Corp
ISTR
$413M
$197K ﹤0.01%
10,705
-1,518
-12% -$28.4K
RDHL
3534
Redhill Biopharma
RDHL
$4.13M
$197K ﹤0.01%
+77
New +$308K
GEL icon
3535
Genesis Energy
GEL
$1.83B
$196K ﹤0.01%
18,301
-2,207
-11% -$24.6K
GOTU icon
3536
Gaotu Techedu
GOTU
$436M
$196K ﹤0.01%
101,244
-77,900
-43% -$217K
PWOD
3537
DELISTED
Penns Woods Bancorp
PWOD
$196K ﹤0.01%
8,275
-968
-10% -$23.2K
ALPN
3538
DELISTED
Alpine Immune Sciences Inc
ALPN
$196K ﹤0.01%
14,098
+9,351
+197% +$116K
MERC icon
3539
Mercer International
MERC
$39M
$195K ﹤0.01%
16,269
-9,815
-38% -$109K
SEEL
3540
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$195K ﹤0.01%
31
+21
+210% +$161K
SCWX
3541
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$194K ﹤0.01%
12,116
+8,037
+197% +$147K
APLT
3542
DELISTED
Applied Therapeutics
APLT
$193K ﹤0.01%
21,498
+3,582
+20% +$47K
VOXX
3543
DELISTED
VOXX International Corporation Class A
VOXX
$193K ﹤0.01%
18,891
+12,529
+197% +$139K
DDD icon
3544
CALL
3D Systems Corp
DDD
$444M
$192K ﹤0.01%
8,900
ICAD
3545
DELISTED
iCAD Inc
ICAD
$192K ﹤0.01%
26,572
-26,375
-50% -$235K
LTRPA
3546
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$192K ﹤0.01%
88,439
+37,257
+73% +$105K
USX
3547
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$192K ﹤0.01%
32,654
+21,658
+197% +$163K
ESCA icon
3548
Escalade
ESCA
$265M
$191K ﹤0.01%
12,037
+7,907
+191% +$143K
CLF icon
3549
CALL
Cleveland-Cliffs
CLF
$6.73B
$190K ﹤0.01%
8,720
-138,700
-94% -$2.99M
ARD
3550
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$190K ﹤0.01%
21,048
-3,073
-13% -$75.2K

Similar funds

Barclays's Q4 2021 Portfolio in Review

As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.

  • Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
  • Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
  • Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
  • Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
  • Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
  • Barclays opened 209 new positions and closed 867 in Q4 2021.
  • Barclays's portfolio value rose 21% quarter-over-quarter to $268B.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.